Skip to main content
. 2023 Nov 15;14:1286700. doi: 10.3389/fimmu.2023.1286700

Figure 3.

Figure 3

RNA-sequencing based determination of proliferation (RPI) (A) of malignant plasma cells from MGUS-, asymptomatic (AMM), symptomatic (MM) and relapsed myeloma patients (MMR) in comparison to normal bone marrow plasma cells (BMPC), memory B-cells (MBC), proliferating plasmablasts (PPC), and human myeloma cell lines (HMCL). Significant differences in comparison to MM are depicted by asterisks (*** P<.001, ** P<0.01). (B) Overall survival and (C) event- free survival. Depicted are Kaplan Maier curves with log-rank based P-value and patients at risk.